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Abstract: Parenteral routes of drug administration are often selected to optimize actual dose of 
drug delivered, assure high bioavailability, bypass first-pass metabolism or harsh gastrointestinal 
environments, as well as maximize the speed of onset. Intramuscular (IM) delivery can be pre-
ferred to intravenous delivery when initiating intravenous access is difficult or impossible. Drugs 
can be injected intramuscularly using a syringe or an automated delivery device (a utoinjector). 
Investigation into the IM delivery dynamics of these methods may guide further improvements in 
the performance of injection technologies. Two porcine model studies were conducted to compare 
differences in dispersion of injectate volume for different methods of IM drug administration. The 
first study compared the differences in the degree of dispersion and uptake of injectate following 
the use of a manual syringe and an autoinjector. The second study compared the spatial spread 
of the injected formulation, or dispersion volume, and uptake of injectate following the use of 
five different autoinjectors (EpiPen® [0.3 mL], EpiPen® Jr [0.3 mL], Twinject® [0.15 mL, 0.3 
mL], and Anapen® 300 [0.3 mL]) with varying needle length, needle gauge, and force applied 
to the plunger. In the first study, the autoinjector provided higher peak volumes of injectate, 
indicating a greater degree of dispersion, compared with manual syringe delivery. In the second 
study, EpiPen autoinjectors resulted in larger dispersion volumes and higher initial dispersion 
ratios, which decreased rapidly over time, suggesting a greater rate of uptake of injectate than 
the other autoinjectors. The differences in dispersion and uptake of injectate are likely the result 
of different functional characteristics of the delivery systems. Both studies demonstrate that 
the functional characteristics of the method for delivering IM injections impact the dispersion 
and uptake of the material injected, which could significantly affect the pharmacokinetics and, 
ultimately, the effectiveness of the drug.
Keywords: anaphylaxis, autoinjector device, injector pen, intramuscular drug administration, 
dispersion volume
Introduction
The key to treating medical emergencies such as anaphylaxis and prolonged seizures is 
rapid administration of the appropriate medications.1,2 Delayed treatment is associated 
with poorer outcomes.3–5 One important variable affecting time to treatment is the route 
of drug administration. The onset of action with oral administration is inherently slow 
and therefore not suitable for patients experiencing a medical emergency. Other routes of 
administration (ie, rectal, intranasal, transdermal, and sublingual) may be inconvenient, 
difficult for administration, or physiologically and/or pharmacologically impractical.6–8
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Parenteral drug therapy usually provides a more rapid 
uptake of drug and is therefore preferred over oral therapy, 
when available. Among the possible parenteral routes, the 
subcutaneous route generally has the longest time to effect 
and is the simplest to administer. The intravenous (IV) route 
has the most rapid onset of action but IV access can be dif-
ficult, time-consuming, and sometimes impossible to achieve. 
The intramuscular (IM) route provides a compromise, since 
it often results in an intermediate time to onset of action and 
can often be accomplished without difficulty. IM administra-
tion of benzodiazepines via an autoinjector has been shown 
to be at least as safe and effective as the IV route for treating 
prolonged convulsive seizures in the prehospital setting.9 An 
additional advantage of IM drug administration is that it may 
provide greater consistency in absorption than subcutaneous 
administration.10–12
There are several methods for delivering drugs by the IM 
route, and recent advances in IM drug transport dynamics13 
may guide further improvements to the performance of cur-
rent and alternative injection technologies. To best evaluate 
the growing variety of methodologies and their unique 
design characteristics, it is important to develop experimental 
models that provide a means to evaluate various devices 
with respect to discrete properties of the IM injection. Our 
 studies build on the work of Wu et al13 which documented the 
mechanical influences of active tissue on drug permeability 
and transport by using isolated muscle model systems. In this 
study, we developed an animal model that has the advantages 
of muscle mass parameters close to human skeletal muscle 
and nonischemic, living tissue. A computed tomography (CT) 
imaging technique was used to measure the dispersion and 
uptake of the injectate. CT image analysis provided a means 
to evaluate the influence of device parameters, such as needle 
length, needle gauge, injection volume, and plunger force (ie, 
speed and pressure of delivery provided either manually or by 
a spring), on specific aspects of IM injection that ultimately 
affect drug pharmacokinetics and effectiveness.
A manual syringe requires that the user applies a force 
sufficient to deliver the drug. The extent of this force is 
dependent on a number of parameters including user dexter-
ity, fluid viscosity, needle length and gauge, friction between 
the syringe plunger and syringe barrel, cross-sectional area 
of the syringe plunger, and plunger displacement.14 An auto-
injector provides a consistent spring force profile to push the 
drug out of the syringe. The internal spring is compressed 
prior to activation and is released either by a button press or 
by applying pressure to the needle end of the autoinjector, 
depending on the design. The spring force is designed to be 
sufficient to deliver the drug, which is affected by the same 
parameters as for the manual syringe.
Two studies using our animal model and imaging 
technique were conducted separately to compare different 
devices used to deliver an IM drug administration. The 
first study compared the use of a manual syringe and an 
autoinjector, and, for each method, assessed whether needle 
length and gauge were related to injectate dispersion volume 
(spatial spread of injectate) and uptake (reduction in injectate 
volume in tissue). The second study compared the impact 
of five different autoinjectors with varying needle length, 
needle gauge, and spring force on the dispersion volume 
and uptake of injectate.
Materials and methods
study 1: autoinjector versus manual 
syringe
The dispersion volumes of the injectate from an autoinjec-
tor (Diazepam Auto-Injector; Pfizer Inc., New York, NY, 
USA)10,15 were compared with that of a manual syringe 
(Monoject™ 3 mL syringe; Covidien, Mansfield, MA, USA) 
using CT imaging in a pig animal model. The study was 
conducted according to US Food and Drug Administration 
Good Laboratory Practice for Nonclinical Studies16 in the 
Department of Radiology at Georgetown University between 
March 18, 2006, and April 29, 2006, under an Institutional 
Animal Care and Use Committee-approved animal care and 
use protocol (#05-021).
Pigs
Nine female Yorkshire pigs were purchased from Thomas D 
Morris, Inc. (Reisterstown, MD, USA). Animals were identi-
fied by the vendor using permanent ear tags. Animals were 
acclimated 3–4 days prior to each investigation. All animals 
were examined upon arrival, housed in a controlled environ-
ment, and fed Purina™ Lab Diet 5084 (Purina Lab Diet, St 
Louis, MO, USA, noncertified) with tap water provided by 
an automatic water system, available ad libitum from the 
day of arrival to the end of study. A total of eight animals 
(one animal died due to anesthetic complications prior to 
injection) were randomized by random card draw and were 
studied in two groups of four animals each (groups P1 and 
P2, Table 1).
injection devices and injectate
The investigation was conducted using eight autoinjectors 
and eight manual syringes. The Diazepam Auto-Injector 
(Pfizer Inc.) was a cylindrically shaped, pressure-activated, 
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Table 1 study details
Study group (n=4/group) Needle gauge (Ga) × length (in) Administration Evaluation
Study 1: Diazepam Auto-Injector versus Monoject™ manual syringe
P1 22×0.6 autoinjector versus 22×0.6 syringe autoinjector in left thigh,  
manual syringe in right thigh
Dispersion and uptake of injectate
P2 20×0.8 autoinjector versus 20×0.8 syringe
Study group (n=4/group) Autoinjector comparison Administration Evaluation
Study 2: Anapen® and Twinject® autoinjectors versus EpiPen® autoinjector
P1 anapen 0.3 ml versus epiPen 0.3 ml each animal was injected with  
epiPen in the left thigh and test  
injector in the right thigh
Dispersion and uptake of injectate
P2 Twinject 0.15 ml versus epiPen® Jr 0.3 ml
P3 Twinject 0.3 ml versus epiPen 0.3 ml
prefilled 3 mL automatic syringe delivery device. One 
version contained a 22 gauge ×0.6 inch (22 Ga ×0.6 in 
[length of needle extended from the device]) needle and 
the other contained a 20 Ga ×0.8 in needle. Two versions 
of the manual (Monoject™, Covidien) 3 mL syringes were 
also used in the study: one with a 22 Ga ×1.5 in needle and 
one with a 20 Ga ×1.5 in needle. A needle depth marker 
(Cook Inc., Bloomington, IN, USA) was manually placed 
and secured onto each Monoject™ needle (Covidien) so 
that the maximum IM penetration of the 22 Ga needle was 
0.6 in and the maximum penetration of the 20 Ga needle was 
0.8 in to ensure direct comparability to the autoinjectors. The 
measurement from the tip of the needle to the proximal edge 
of the needle depth marker was assessed with digital calipers 
(VWR, Clarksburg, MD, USA).
The injectate used in both the autoinjector and the standard 
syringe was a solution containing 0.25 mL per mL Omnipaque 
300™ (Amersham Health Inc., Princeton, NJ, USA) com-
bined with 0.75 mL per mL of a solution made using the 
following formula (per mL solution): 447.50 mg propylene 
glycol USP, 94.50 mg ethanol (95%) USP, 17 mg benzyl 
alcohol NF, 45.50 mg sodium benzoate NF, 3.75 mg benzoic 
acid USP, and a sufficient quantity of purified water to bring 
solution to 1 mL. Both autoinjectors and syringes were pre-
filled with 2 mL of injectate.
study 1 procedure
Animals were weighed and anesthetized in the Division of 
Comparative Medicine (Georgetown University) on the day 
of testing. Anesthesia was induced by the administration of 
IM ketamine/xylazine given in the lateral neck muscles or 
rear leg and IV atropine and thiopental given via an ear vein 
catheter. The animals were intubated, ventilated, and placed 
on isoflurane gas (1%–3%) to maintain anesthesia. During 
transport and throughout the study, the pigs were placed on 
their backs on a V-trough and oriented on the CT table with 
the head toward the front of the gantry. Anesthetized pigs 
received two simultaneous IM injections of 2 mL injectate. 
Two technicians performed the injections: one administered 
the injectate with the manual syringe (right thigh) and the 
other used the autoinjector (left thigh). To identify equivalent 
injection sites on each thigh, each target was found by 
palpating the patella and then measuring 3 cm medially or 
laterally from the patella into the muscle mass and marked 
with indelible ink prior to the injection.
Tissue at each of the marked sites was pinched and rotated 
to allow better access to the designated muscle belly, and 
either the autoinjector or syringe was applied and deployed. 
Autoinjectors and syringes were held in place for 5 seconds 
after completing the injection. Following the injection, the 
length of the manual syringe needle was remeasured using 
the digital calipers to evaluate whether or not the needle 
depth marker had shifted.
The first group (P1) was injected with the 22 Ga needles 
of the manual syringe and autoinjector; the second group (P2) 
was injected with the 20 Ga needles of the manual syringe 
and autoinjector.
cT imaging analysis
CT imaging (Somatom Volume Zoom CT Scanner with 
fluoroscopy capability; Siemens, Forchheim, Germany) was 
used to measure the dispersion parameters of the injectate. 
An initial CT fluoroscopy image was obtained during the 
injection, and then a series of CT volumes was obtained 
following completion of injection. The first of these CT 
volumes was obtained approximately 10 seconds from the 
time of injection to the first scan. Subsequent CT volumes 
were then obtained at 1, 5, 10, 15, 20, 30, 45, and 60 minutes 
after injection. The CT images were acquired using 165 mAs 
at 120 kV with a rotation time of 0.5 seconds. Narrow col-
limation (1.0 mm) was used with a 3.0 mm slice width and 
a rotation/table feed of 5.0 mm.14 A medium smooth recon-
struction kernel (B30f) and a reconstruction increment of 
1.0 mm were used.
CT image analysis was performed using the Analyze© 
software (Mayo Clinic, Rochester, MN, USA). Analyze 5.0 
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was used. Total volume measure (in mm3) based on voxel 
signal intensity was derived for each time point using a 
manual threshold technique.17 An intensity threshold that 
adequately visualized injectate and bone was manually identi-
fied in the first CT scan. Scans collected at subsequent time 
intervals use this same threshold to segment the CT dataset. 
The injectate volume is identified through a region growing 
method, seeded with manually selected points identifying 
injectate site. For each segmented injectate volume, the mean 
and standard deviation of voxel intensities were computed. 
For each trial, a reduction in the injectate volume over time 
was interpreted as representing dispersion of injectate from 
tissue. The average rate of uptake of injectate was calculated 
as ∆V/∆t = [(V
p
 - V
60
)/(t
60
 - t
p
)]  where V
p
 = peak volume, 
V
60
 = volume at 60 minutes, t
p
 = time point of peak volume, 
and t
60
 = 60-minute time point.
Animals were euthanized at the end of the study, following 
completion of CT scans (on March 18 and March 26), using 
a commercially available euthanasia solution (Euthasol™; 
Virbac AH, Inc., Fort Worth, TX, USA).
A statistical analysis of the results was not performed 
since the number of animals included in this study did not 
support a statistical approach.
study 2: autoinjectors with different 
mechanical properties
The parameters relating to dispersion volume and uptake 
were measured following injections with five autoinjectors 
(EpiPen 0.3 mL and EpiPen Jr 0.3 mL [Mylan Specialty LP, 
Basking Ridge, NJ, USA], Twinject 0.15 mL and Twinject 0.3 
mL [Shionogi Pharma, Inc., Atlanta, GA, USA], and Anapen 
300 0.3 mL [Lincoln Medical, Wiltshire, UK] autoinjec-
tors) using CT imaging in a pig animal model. The study 
was  performed in the Division of Comparative Medicine at 
Georgetown University on March 1, 2010 and July 24, 2010 
under an Institutional Animal Care and Use Committee-
approved animal care and use protocol (#10-005).
Pigs
Thirteen female Yorkshire pigs were purchased from Thomas 
D Morris, Inc. Animals were identified by the vendor using 
permanent ear tags. One animal in Study 2 was used for a 
prestudy procedural assessment and was euthanized on the 
day after arrival and not entered into the study. This animal 
was used to determine the attachment method for a denim 
patch (to be injected through) and the specific location for 
the injection sites to optimize the injection procedure. As in 
the previous study, the remaining animals were examined 
upon arrival, housed in a controlled environment, and pro-
vided with food and water as described above. A total of 12 
animals were placed into three groups of four animals each 
(groups P1, P2, and P3, Table 1).
injection devices and injectate
Each study group was used to test two autoinjector devices 
as follows: P1) Anapen 300, a round, prefilled, pressure-
activated, automatic syringe (27 Ga ×0.3 in [length of 
needle extended from the device]) intended to deliver 
0.3 mL, and EpiPen, an oval, prefilled, pressure-activated, 
automatic syringe (22 Ga ×0.6 in) intended to deliver 
0.3 mL; P2) Twinject, a round, prefilled, automatic syringe 
(25 Ga ×0.5 in needle) intended to deliver 0.15 mL and 
EpiPen Jr, an oval, pressure-activated, prefilled automatic 
syringe (22 Ga ×0.5 in) intended to deliver 0.3 mL; and P3) 
Twinject (25 Ga ×0.5 in), as described, intended to deliver 
0.3 mL, and EpiPen Jr (22 Ga ×0.5 in) as described, intended 
to deliver 0.3 mL (Table 1). The functional characteristics of 
each autoinjector type that could influence dispersion of the 
injectate within muscle are listed in Table 2.
study 2 procedure
Anesthesia was induced by the administration of Telazol 
(Zoetis, Fort Dodge Animal Health, New York, NY, USA) 
(6 mg/kg, IM), and atropine (0.5 mg/kg, IM) given in the 
lateral neck muscles or rear leg. The animals had an ear 
Table 2 Typical functional characteristics of autoinjectors used in study 1 and study 2
Spring forcea (lbs) Needle extended length (in)b Needle gauge (Ga) Dispense time (s) Activation forcec (lbs)
Diazepam 2 ml 23d 0.51e 22 1.6e 3.6e
Diazepam 2 ml 23d 0.75f 20 1.0f 4.3f
anapen® 0.3 ml 2.1g 0.29g 27g 0.78g 2.1g
Twinject® 0.15 ml 6.5g 0.48g 25g 0.28g 5.6g
Twinject 0.3 ml 6.5g 0.51g 25g 0.63g 5.9g
epiPen® 0.3 ml 22.7g 0.59g 22g 0.29g 6.6g
epiPen® Jr 0.3 ml 23.6g 0.52g 22g 0.30g 5.7g
Notes: aspring force: the force applied to plunger the moment the drug is dispensed; bneedle extended length: the length of the needle that is available to enter the subject’s 
thigh; cactivation force: the force required to trigger the automated injection; ddiazepam auto-injectors use the same spring as the epiPen, implicating that the spring force 
will be typically similar; ecertificate of Conformance for Lot RP 452-2, data from Meridian Medical Technologies; fcertificate of Conformance for Lot RP-476-B, data from 
Meridian Medical Technologies; gr01-651 Functionality report, data from Meridian Medical Technologies.
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vein catheter placed, were intubated, ventilated, and given 
isoflurane (1%–3%) gas as maintenance anesthesia. The 
anesthetized pigs were placed on the CT table in a V-trough 
on their backs. The injection sites (one per thigh) were then 
identified using digital calipers to measure 3 cm laterally 
from the top of the patella. The injection site was marked 
with indelible ink directly on the skin prior to injection. Both 
the right and left thighs were injected simultaneously, with 
different technicians performing each injection. Each autoin-
jector was positioned ∼90° to the injection surface. Following 
activation, the autoinjectors were held in place for 5 seconds 
to ensure complete delivery of the injectate.18
cT imaging analysis
CT imaging (Somatom Emotion 16 CT Scanner; Siemens) 
was used to determine the injectate dispersion into the muscle 
and subsequent uptake of the injectate over time. Serial CT 
images were acquired as previously described for Study 1. 
However, the interval between images was shorter than was 
used for Study 1, as was the total time period over which the 
series was collected. This change was made in order to get 
a better definition of the time resolution for injectate uptake 
during the earlier time points when the greatest change was 
observed in Study 1. An initial scan was obtained as soon 
as the technicians performing the injection left the room 
(designated time zero) and then at times 1, 2, 3, 4, 5, 7, 9, 11, 
13, and 15 minutes postinjection. CT images were acquired 
at 110 kV with a rotation time of 0.1 seconds. Narrow col-
limation (1.0 mm) was used as before, with a 1.0 mm slice 
width and a medium smooth reconstruction kernel (B30f), 
with a reconstruction increment of 1.0 mm.
Analysis of CT images was performed as described 
previously. A statistical analysis of the results was not per-
formed since the number of animals included in this study 
did not support a statistical approach.
After removal of the autoinjectors from the injection site, 
the postinjection exposed needle lengths were determined 
using CT imaging. The postinjection needle scans were loaded 
into Analyze (Analyze 7.0 Software Suites, AnalyzeDirect, 
Inc., Overland Park, KS, USA), and the threshold was adjusted 
so that only the needle and plastic housing were visible. For 
each article, the tip of the needle was chosen as the start point 
and the base of the needle proximal to the plastic housing was 
chosen as the end point when measuring.
Animals were euthanized as described previously. The 
pig carcasses were returned to the necropsy room and the skin 
directly over the injection site was incised with a scalpel, and 
the depth of the combined skin/fat layer was measured using 
digital calipers. The skin/fat layer was quantified to determine 
that the depth of tissue was consistent and to ensure that the 
extended needles of the autoinjectors were long enough to 
reach the muscle tissue underlying the fat layer.
Results
study 1: autoinjector versus syringe
Injection using both autoinjectors (20 Ga ×0.8 in and 
22 Ga ×0.6 in) resulted in larger peak dispersion volumes 
(8,677 and 7,049 mm3, respectively) than injections using 
the manual syringes (6,917 mm3 for the 0.8 in syringe and 
6,521 mm3 for the 0.6 in syringe), as shown in Figure 1. In 
addition, use of devices (autoinjector or syringe) with 20 
Ga ×0.8 in needles (P2) resulted in larger dispersion volumes 
than use of devices with 22 Ga ×0.6 in needles (P1) (Figure 1), 
suggesting that needle gauge and/or length affected injectate 
delivery. Autoinjection with the 20 Ga ×0.8 in needle gave 
both the highest peak dispersion volume (8,677 mm3; Figure 
1) and greatest uptake (29% peak volume remaining in the 
tissue at 60 minutes; Figure 2) of the four injection groups 
studied.
Additionally, both autoinjectors showed more rapid and 
complete uptake of the injectate within the 60-minute period 
studied compared to the syringes, as evidenced by the per-
centage of peak volume remaining in the muscle tissue at 
60 minutes (Figure 2: 30% for the 20 Ga ×0.8 in autoinjector 
versus 87% for the 20 Ga ×0.8 in syringe and 71% for the 
22 Ga ×0.6 in autoinjector versus 83% for the 22 Ga ×0.6 in 
syringe). The average rate of uptake at the 60-minute time 
point for the 20 Ga ×0.8 in autoinjector and the 22 Ga ×0.6 in 
autoinjector was 111.5 and 38.1 mm3/min, respectively, as 
compared to 15.8 and 14.0 mm3/min for the 20 Ga ×0.8 in 
syringe and 22 Ga ×0.6 in syringe, respectively.
Across the four injection devices (autoinjector and 
syringe, each with two needle types), there was a positive 
relationship between peak dispersion volume and percentage 
uptake, as indicated by the percentage reduction in dispersion 
volume from peak to 60 minutes (Figure 3).
study 2: autoinjectors with different 
mechanical properties
The postinjection exposed needle lengths were determined 
by CT analysis for all autoinjectors in this study. EpiPen 
exposed needle lengths ranged from 0.59 to 0.62 in (15.0–
15.7 mm). Twinject 0.30 mL exposed needle lengths ranged 
from 0.48 to 0.50 in (12.2–12.7 mm). EpiPen Jr exposed 
needle lengths ranged from 0.56 to 0.58 in (14.2–14.7 mm). 
Twinject 0.15 mL exposed needle lengths ranged from 0.47 
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to 0.52 in (11.9–13.2 mm). Anapen exposed needle lengths 
ranged from 0.29 to 0.33 in (7.4–8.4 mm).
The postmortem measurement of the combined depth of 
the skin/fat layer directly under the autoinjection site dem-
onstrated a similar measured depth of skin/fat layer in the 
left thigh and right thigh across all animals in all groups (P1, 
P2, and P3) of 2.18±0.51 mm (mean ± standard deviation) 
(0.086±0.02 in) and 2.31±0.36 mm (0.09±0.01 in), respec-
tively (Table 3). The average depth of the skin/fat layer was 
2.24±0.44 mm (0.09±0.02 in).
There were differences in tissue dispersion volume 
among the autoinjectors tested. Study group P1 compared 
Anapen and EpiPen, both delivering 0.3 mL injectate. 
The initial dispersion volume was greater for EpiPen 
(949.76 mm3) than for Anapen (576.70 mm3), and the 
injectate reached its peak dispersion volume in a shorter 
time for EpiPen (1 minute) than for Anapen (9 minutes). In 
addition, there was greater uptake of the injectate from the 
site of injection 15 minutes postinjection for EpiPen (80%) 
than for Anapen (,5%).
Study group P3 compared Twinject 0.3 mL and EpiPen, 
both delivering 0.3 mL injectate. The EpiPen had a greater 
initial injectate dispersion volume (791.94 mm3) than did 
Twinject 0.3 mL (721.18 mm3). There was greater uptake 
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of the injectate 15 minutes postinjection for EpiPen (97%) 
than for Twinject 0.3 mL (,5%).
Study group P2 compared Twinject delivering 0.15 mL 
and EpiPen Jr delivering 0.3 mL. EpiPen Jr had a greater 
peak injectate dispersion volume (934.77 mm3) than Twinject 
0.15 mL (412.04 mm3). It was noted that the EpiPen Jr 0.3 mL 
injects twice the volume of injectate than the Twinject 
0.15 mL. To obtain a more effective interpretation of the dif-
ference in dispersion between the two devices, the data was 
normalized by dividing the dispersion volume by the injectate 
volume (Figure 4), resulting in a dispersion ratio (average 
measured dispersion volume/target injectate volume). Of the 
three test devices evaluated in this study (Anapen, EpiPen, 
and Twinject) the Anapen had the lowest initial dispersion 
ratio of 1.9. Twinject 0.15 mL had a higher initial dispersion 
ratio than Twinject 0.3 mL (2.7 versus 2.4), both of which 
were higher than Anapen. The EpiPen autoinjectors achieved 
higher initial dispersion ratios (range: 2.6–3.2) than Anapen 
and higher than or similar dispersion ratios to Twinject. 
Table 3 study 2: injection site skin fat layer measurements
Study comparison  
and animal
Autoinjector applied  
to left thigh (Ga × in)
Autoinjector applied  
to right thigh (Ga × in)
Measured skin/fat depth (mm [in])
Left thigh (EpiPen®) Right thigh (test injector)
Study group P1
animal 1 anapen® 
27×0.3
epiPen 
22×0.6
1.86 (0.07) 2.41 (0.10)
animal 2 anapen 
27×0.3
epiPen 
22×0.6
1.65 (0.07) 2.04 (0.08)
animal 3 anapen 
27×0.3
epiPen 
22×0.6
1.80 (0.07) 1.91 (0.08)
animal 4 anapen 
27×0.3
epiPen 
22×0.6
2.64 (0.10) 2.38 (0.09)
Mean ± sD 1.99±0.44 (0.08±0.02) 2.19±0.25 (0.09±0.01)
Study group P2
animal 1 Twinject® 
25×0.5
epiPen® Jr 
22×0.5
2.01 (0.08) 1.93 (0.08)
animal 2 Twinject 
25×0.5
epiPen Jr 
22×0.5
2.18 (0.09) 2.51 (0.10)
animal 3 Twinject 
25×0.5
epiPen Jr 
22×0.5
2.24 (0.09) 2.22 (0.09)
animal 4 Twinject 
25×0.5
epiPen Jr 
22×0.5
3.57 (0.14) 2.37 (0.09)
Mean ± sD 2.50±0.72 2.26±0.25
Study group P3
animal 1 Twinject 
25×0.5
epiPen 
22×0.6
1.91 (0.08) 3.27 (0.13)
animal 2 Twinject 
25×0.5
epiPen 
22×0.6
2.09 (0.08) 2.00 (0.08)
animal 3 Twinject 
25×0.5
epiPen 
22×0.6
1.93 (0.08) 2.28 (0.09)
animal 4 Twinject 
25×0.5
epiPen 
22×0.6
2.26 (0.09) 2.35 (0.09)
Mean ± sD 2.05±0.16 2.48±0.55
Abbreviation: sD, standard deviation.
A notable difference between EpiPen and the other two 
autoinjectors was the decrease in dispersion volume over 
the 15-minute testing period. For EpiPen autoinjectors, the 
dispersion ratio was ,30% of the initial value by 15 minutes, 
suggesting substantial uptake of injectate, whereas the dis-
persion ratio for Anapen and Twinject remained relatively 
constant, at .95% of the initial value by 15 minutes, sug-
gesting negligible uptake (Figure 4).
Discussion
Our investigations demonstrated that the functional char-
acteristics of IM delivery systems influence dispersion and 
uptake of the injected material. In the first study, there was 
a clear difference between the autoinjector and the manual 
syringe with regard to characteristics of the injectate within 
the tissue. The greater dispersion volume of injectate for the 
autoinjectors, representing a wider tissue contact, is likely 
due to the greater force of injection provided by the spring 
within the autoinjector compared to that anticipated for 
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manual injection with a syringe. The autoinjector used in the 
first study has a spring force of ∼23 lbs (Table 2), whereas 
a comparable design parameter for manual strength when 
using a syringe to give an injection, sustained thumb–finger 
grip strength, is 6.4–8 lbs for the 5th percentile of males.19 
The results also provide evidence that needle gauge and/or 
length affect injectate dispersion, since for both the manual 
syringe and the autoinjector, the 20 Ga ×0.8 in needle 
produced a greater dispersion volume of injectate than for 
devices with the 22 Ga ×0.6 in needle. This relationship 
could be a result of greater speed of delivery through the 
larger diameter (lower gauge) or the deeper injection depth 
of the 0.8 in needle.
The results of Study 1 also suggest that the greater disper-
sion provided by the autoinjector delivery systems correlates 
with greater uptake of the injected material. The positive 
relationship shown between peak dispersion volume and 
percentage uptake across the four injection devices (auto-
injector and syringe, each with two needle types) could be 
because with a larger dispersion volume, the injectate comes 
into greater contact with the vascular bed, leading to more 
rapid absorption of material.
The results of Study 2 confirmed and extended those of 
Study 1. In particular, there were substantial differences 
in the dispersion and uptake of injectate among autoinjec-
tors that differed with regard to spring force (ie, speed and 
pressure of delivery), needle gauge, needle length, injection 
volume, and resulting dispense time. The most notewor-
thy difference in injectate parameters was between the 
EpiPen autoinjectors and the two other brands, Anapen and 
Twinject. The EpiPen resulted in greater dispersion vol-
ume, and substantially greater uptake at the 15-minute 
postinjection time point than either Anapen or Twinject. 
Since the most substantial functional difference between 
EpiPen and the other autoinjectors is the spring force 
which drives the injection18 (23 lbs for EpiPen compared 
to 6 lbs for Twinject and 2.1 lbs for Anapen; Table 2), 
this factor is most likely responsible for the difference 
in dispersion and uptake of injectate. The lower gauge 
(larger needle diameter) of the EpiPen needle may also 
have contributed to the differences among autoinjectors, 
since this parameter affects injectate dispersion volume, 
as observed in Study 1.
One characteristic of the autoinjectors which could have 
contributed to a difference in dispersion volume is extended 
needle length. If any of the autoinjectors had an extended 
needle length that was not sufficient to reach the muscle layer, 
this could have produced a significant decrease in the average 
dispersion volume for that type of autoinjector. However, the 
results demonstrate that this was not a factor in this study, 
since the shortest postinjection needle length was 7.4 mm 
and the thickest skin/fat layer was 2.68 mm. Thus, all of 
the needles penetrated well beyond the skin and fat, and the 
autoinjections were given into muscle in all animals.
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Figure 4 Dispersion volume/target injectate volume ratio over time for autoinjectors (study 2).
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It is worth emphasizing that the greatest difference 
between EpiPen and the other autoinjectors was the percent-
age uptake of injectate. This is the measure most likely to 
correlate to drug serum concentration, which is a key con-
tributor to the effectiveness of the treatment.
Adrenaline administration by autoinjector is viewed as the 
most effective first-line treatment for the management of ana-
phylaxis in the community. Autoinjectors provide fixed dosing, 
consistent needle penetration and depth, and can be adminis-
tered quickly with a consistent dispersion pattern, which are 
important attributes in an anaphylaxis emergency. It is more 
difficult for patients and caregivers to achieve accurate and 
timely IM self-administration of adrenaline using an ampoule, 
needle, and syringe. The use of autoinjectors is associated 
with a higher cost in a health-care setting, whereas a manual 
syringe and needle may offer a more cost-effective treatment. 
However, the force of injection and needle depth associated 
with syringe and needle use may be more variable.
The limitations of this study include the small number of 
animals tested in each device group. Furthermore, injections 
into subcutaneous tissue were not part of this study, so the 
dispersion characteristics described apply only to injections 
into muscle tissue. Given the robust nature of the results, 
however, it is likely that the conclusions accurately reflect 
the relationship between functional aspects of drug delivery 
devices and the dispersion volume and uptake of injectate. 
Also, because individual functional aspects of the devices 
were not tested in isolation, any one aspect (eg, spring force) 
cannot definitely be attributed to a difference in dispersion 
volume or uptake. Although an understanding of the rela-
tionship between functional aspects of the devices and the 
force and speed of injectate delivery provides a reasonable 
basis for interpreting what led to differences among devices, 
additional studies are required to confirm the conclusions 
presented here. At the time of this study, the Anapen was 
not available in the US, but has been available in Europe 
since 2003. The Twinject autoinjector used in Study 2 has 
been withdrawn from the market since the completion of this 
study, and replaced with a similar device called Adrenaclick. 
There have been no functional changes affecting the design 
of EpiPen since this study was conducted that would affect 
the results seen in this study. The EpiPen design used in this 
study is the one that is currently commercially available.
Conclusion
This study demonstrated the effective use of an animal 
model and an imaging methodology to assess the impact of 
specific functional properties of injection devices on discrete 
parameters of an IM injection. Uptake of injected material, 
which is likely to contribute significantly to serum levels and 
effectiveness of a drug, was greatest under circumstances in 
which the force of injection was highest. This was true among 
different autoinjector types and when comparing autoinjector 
delivery to injection by a manual syringe. Needle size includ-
ing gauge and length contributed to a lesser extent, with lower 
gauge (larger diameter needle) resulting in greater disper-
sion and uptake. These results may be used to guide further 
improvements to the performance of injection technologies.
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